Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Circulating 20S proteasome in patients with non-metastasized breast cancer.

Hoffmann O, Heubner M, Anlasik T, Winterhalter M, Dahlmann B, Kasimir-Bauer S, Kimmig R, Wohlschlaeger J, Sixt SU.

Anticancer Res. 2011 Jun;31(6):2197-201.

PMID:
21737641
2.

The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer.

Heubner M, Wimberger P, Dahlmann B, Kasimir-Bauer S, Kimmig R, Peters J, Wohlschlaeger J, Sixt SU.

Gynecol Oncol. 2011 Feb;120(2):233-8. doi: 10.1016/j.ygyno.2010.10.014. Epub 2010 Nov 13.

PMID:
21075439
3.

High plasma proteasome levels are detected in patients with metastatic malignant melanoma.

Stoebner PE, Lavabre-Bertrand T, Henry L, Guiraud I, Carillo S, Dandurand M, Joujoux JM, Bureau JP, Meunier L.

Br J Dermatol. 2005 May;152(5):948-53.

PMID:
15888151
4.

Heightened levels of circulating 20S proteasome in critically ill patients.

Roth GA, Moser B, Krenn C, Roth-Walter F, Hetz H, Richter S, Brunner M, Jensen-Jarolim E, Wolner E, Hoetzenecker K, Boltz-Nitulescu G, Ankersmit HJ.

Eur J Clin Invest. 2005 Jun;35(6):399-403.

PMID:
15948901
5.

Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium.

Wohlschlaeger J, Sixt SU, Stoeppler T, Schmitz KJ, Levkau B, Tsagakis K, Vahlhaus C, Schmid C, Peters J, Schmid KW, Milting H, Baba HA.

J Heart Lung Transplant. 2010 Jan;29(1):125-32. doi: 10.1016/j.healun.2009.07.022. Epub 2009 Oct 17.

PMID:
19837610
6.

Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis.

Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R.

BMC Cancer. 2008 Mar 20;8:77. doi: 10.1186/1471-2407-8-77.

7.

Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanoma.

Henry L, Lavabre-Bertrand T, Douche T, Uttenweiler-Joseph S, Fabbro-Peray P, Monsarrat B, Martinez J, Meunier L, Stoebner PE.

Exp Dermatol. 2010 Dec;19(12):1054-9. doi: 10.1111/j.1600-0625.2010.01151.x. Epub 2010 Aug 12.

PMID:
20707810
8.

Proteolytic activity and expression of the 20S proteasome are increased in psoriasis lesional skin.

Henry L, Le Gallic L, Garcin G, Coux O, Jumez N, Roger P, Lavabre-Bertrand T, Martinez J, Meunier L, Stoebner PE.

Br J Dermatol. 2011 Aug;165(2):311-20. doi: 10.1111/j.1365-2133.2011.10447.x. Epub 2011 Jul 11.

PMID:
21740404
9.

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.

PMID:
8931609
10.

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.

Hebbar M, Révillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J, Peyrat JP.

Clin Cancer Res. 1998 Feb;4(2):373-80.

12.

Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.

Bando H, Matsumoto G, Bando M, Muta M, Ogawa T, Funata N, Nishihira J, Koike M, Toi M.

Jpn J Cancer Res. 2002 Apr;93(4):389-96.

PMID:
11985788
13.

Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease.

Blandini F, Sinforiani E, Pacchetti C, Samuele A, Bazzini E, Zangaglia R, Nappi G, Martignoni E.

Neurology. 2006 Feb 28;66(4):529-34.

PMID:
16505307
14.
15.

ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.

Meenakshi A, Kumar RS, Kumar NS.

J Immunoassay Immunochem. 2002;23(3):293-305.

PMID:
12227416
16.

Detection of circulating tumor cells in metastatic breast cancer patients.

Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S.

Endocr Regul. 2011 Jul;45(3):113-24.

PMID:
21793623
17.

Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases.

Taubert H, Blümke K, Bilkenroth U, Meye A, Kutz A, Bartel F, Lautenschläger C, Ulbrich EJ, Nass N, Holzhausen HJ, Koelbl H, Lebrecht A.

Gynecol Oncol. 2004 Jan;92(1):256-61.

PMID:
14751168
18.

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.

Pierga JY, Bonneton C, Vincent-Salomon A, de Cremoux P, Nos C, Blin N, Pouillart P, Thiery JP, Magdelénat H.

Clin Cancer Res. 2004 Feb 15;10(4):1392-400.

19.

Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies.

Lavabre-Bertrand T, Henry L, Carillo S, Guiraud I, Ouali A, Dutaud D, Aubry L, Rossi JF, Bureau JP.

Cancer. 2001 Nov 15;92(10):2493-500.

PMID:
11745181
20.

The roles of ubiquitin and 26S proteasome in human obesity.

Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, Fan K.

Metabolism. 2009 Nov;58(11):1643-8. doi: 10.1016/j.metabol.2009.05.020. Epub 2009 Jul 17.

PMID:
19616267

Supplemental Content

Support Center